From CEO

Promise Better Care with Innovation and Integrity

From CEO

Since the inception of SoliPharma, SoliPharma has experienced an exponential growth both in the type of services provided, as well as the breadth and depth of the product portfolio we own. Based on already demonstrated business model, SoliPharma strives to be a technology-driven and market-driven company, and will keep forging ahead on our path to success. On behalf of the entire management team, I want to express our sincere gratitude to all of your supports along the way.

SoliPharma team believe in core value of Never Compromise Integrity. We aim to the mission of Bring Challenging Molecules to Global Markets and envision ourselves to be the Leader of Specialty Pharmaceutical Products. Empowered by SoliTech® technology, we dedicate to deliver high quality drug faster to the patients to address their unmet medical needs.

I envision SoliPharma becomes a global specialty pharmaceutical company. I also want to thank all our business partners (API suppliers as well as FDF manufacturers) for your solid support for building mutually beneficial businesses one after another. On our path of growth, only with your continuous supports can SoliPharma achieve our challenging goals and bring value to every partner in the business we are building together.

SoliPharma is a young company. Bringing its vast of knowledge and experience accumulated in their previous work life in North America, the top management team also cultivate Sincere, Optimistic, Leading, Innovation, Team (Soli-Team) environment for all employees for their future professional growth in the industry. We welcome talents to join SoliPharma and make your strokes on the canvas of the future SoliPharma.

Xiaoxia Sheng, Ph.D.
President & CEO